ORKA NASDAQ
Oruka Therapeutics, Inc.
1W: +1.5%
1M: -14.0%
3M: +34.9%
YTD: +226.8%
1Y: +485.8%
3Y: +608.4%
5Y: +358.7%
$92.38
+0.73 (+0.80%)
Weekly Expected Move ±5.8%
$82
$87
$92
$98
$103
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.6B
52W Range14.67-115.52
Volume585,299
Avg Volume1,214,222
Beta-0.39
Dividend—
Analyst Ratings
Company Info
CEOLawrence Otto Klein
Employees68
SectorHealthcare
IndustryBiotechnology
IPO Date1997-08-08
Websiteorukatx.com
855 Oak Grove Avenue
Menlo Park, CA 94025
US
Menlo Park, CA 94025
US
203-554-7604
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Latest News
Q3 EPS Estimate for Oruka Therapeutics Lowered by Analyst
ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
BlackRock Inc. Purchases Shares of 4,990,181 Oruka Therapeutics, Inc. $ORKA
Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month High – Here’s What Happened
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Sandler Laura Lee | S-Sale | 1,000 | $91.05 | 2026-09-01 |
| Sandler Laura Lee | S-Sale | 4,000 | $92.01 | 2026-09-01 |
| Klein Lawrence Otto | S-Sale | 6,604 | $90.79 | 2026-09-01 |
| Klein Lawrence Otto | S-Sale | 63,596 | $91.90 | 2026-09-01 |
| Klein Lawrence Otto | S-Sale | 4,800 | $92.44 | 2026-09-01 |